Schedule 13G ownership disclosure

aTYR PHARMA INC

Security class unavailable · CUSIP: 002120103

Event date: 2019-04-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,393,715
Percent of class
16.1600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-19-000493
Form type
SC 13G
Filer
FEDERATED HERMES, INC.
CIK
CIK 1056288
Filed
Apr 22, 2019
Reporting period
Apr 12, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub